ursodeoxycholic acid Tablets 200 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
WHO
Manufacturer #21287
This CTD dossier owner and manufacturer aims to make a meaningful contribution to patients by improving current medical practices. They believe in science, take risks for innovations, learn from mistakes, and humbly serve the patients. It is committed to delivering First in Class, and Best in Class therapeutics to meet the unmet medical needs of patients to advance science. They pursue innovation through ethics and performance-oriented culture.
Ursodeoxycholic acid is a bile acid used to treat gallstones as well as to treat and prevent the progression of cystic fibrosis-related liver disorders. Suppliers of ursodeoxycholic acid market it in the form of 150mg, 250mg and 500mg oral tablets and capsules.
The market for ursodeoxycholic acid is relatively competitive, populated with numerous manufacturing companies and suppliers. The largest manufacturers of ursodeoxycholic acid market globally are companies Mitsubishi Tanabe Pharma, Daewoong Chemical, and PharmaZell, Glenmark Pharmaceuticals, Dipharma Francis, Errengierre, and Grindeks.
Ursodeoxycholic acid suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified ursodeoxycholic acid manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 50 (250mg) tablets of ursodeoxycholic acid fall into an approximate range of 12,00 EUR to 15,00 EUR, whereas the equivalent amount of 500mg tablets cost from 25,00 EUR to 30,00 EUR.